Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study
Kristian Hellenkamp, Piotr Pruszczyk, David Jiménez, Anna Wyzgal, Deisy Barrios, Michal Ciurzynski, Raquel Morillo, Lukas Hobohm, Karsten Keller, Katarzyna Kurnicka, Maciej Kostrubiec, Rolf Wachter, Gerd Hasenfuß, Stavros Konstantinides, Mareike Lankeit
Source: Eur Respir J, 51 (4) 1702037; 10.1183/13993003.02037-2017
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kristian Hellenkamp, Piotr Pruszczyk, David Jiménez, Anna Wyzgal, Deisy Barrios, Michal Ciurzynski, Raquel Morillo, Lukas Hobohm, Karsten Keller, Katarzyna Kurnicka, Maciej Kostrubiec, Rolf Wachter, Gerd Hasenfuß, Stavros Konstantinides, Mareike Lankeit. Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study. Eur Respir J, 51 (4) 1702037; 10.1183/13993003.02037-2017
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: